Skip to main content
SpringerLink
Log in

Engraftment of T-cell-depleted bone marrow in murine models for allogeneic bone marrow transplantation

  • Chapter
Bone Marrow Transplantation

Part of the book series: Cancer Treatment and Research ((CTAR,volume 50))

Abstract

Bone marrow transplantation is being increasingly used in humans [1]. In genetically identical twins there are no immunologic barriers to bone marrow transplantation, but in other circumstances genetic disparities result in immune-related complications, including graft rejection and graft-versus-host disease (GVHD) [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Thomas ED, Clift RA, Storb R. Indications for marrow transplantation. Ann Rev Med 1984; 35:1.

    Article  PubMed  CAS  Google Scholar 

  2. Gale RP, Reisner Y. Graft rejection and graft-versus-host disease: Mirror images. Lancet 1986; 1:1468.

    Article  PubMed  CAS  Google Scholar 

  3. O’Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Kernan N, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sang 1986; 51(2):81.

    Article  PubMed  Google Scholar 

  4. Fischer A, Blanche S, Le Deist F, Gaud C, Veber F, Debre M, Gerota I, Lopez M, Griscelli C. HLA mismatched bone marrow transplantation in inherited disorders. In: T Cell Depletion in Allogeneic Bone Marrow Transplantation, Martelli MF, Grignani F, Reisner Y, eds. Ares-Serono Symposia, Rome, 1988:179.

    Google Scholar 

  5. O’Reilly RJ, Collins NH, Kernan N, Brochstein J, Dinsmore R, Kirkpatrick D, Siena S, Keever C, Shank B, Wolf L, Dupont B, Reisner Y. Transplantation of marrow depleted of T cells by soybean lectin agglutination and E-rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients. Transplant Proc 1985; 17:455.

    Google Scholar 

  6. Hansen JA, Anasetti PG, Beatty PG, Martin PJ, Amos D, Thomas ED. Marrow transplants from HLA haploidentical donors: Failure to engraft and late graft failure. In: T Cell Depletion in Allogeneic Bone Marrow Transplantation, Martelli MF, Grignani F, Reisner Y, eds. Ares-Serono Symposia, Rome, 1988:111.

    Google Scholar 

  7. Apperley JF, Mauro FR, Goldman JM. Bone marrow transplantation for chronic myeloid leukemia in first chronic phase: Risk factors for relapse. In: T Cell Depletion in Allogeneic Bone Marrow Transplantation, Martelli MF, Grignani F, Reisner Y, eds. Ares-Serono Symposia, Rome, 1988:235.

    Google Scholar 

  8. Gengozian N, Carlson DE, Allen EM. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure rates. Transplantation 1969; 7:259.

    Article  PubMed  CAS  Google Scholar 

  9. Cudkowicz G, Bennett M. Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 1971; 134:83.

    Article  PubMed  CAS  Google Scholar 

  10. Lotzova E, Cudkowicz G. Hybrid resistance to parental NZW bone marrow grafts. Transplantation 1971; 12:130.

    Article  PubMed  CAS  Google Scholar 

  11. Lotzova E, Cudkowicz G. Hybrid resistance to parental WB/Re bone marrow grafts. Transplantation 1972; 13:256.

    Article  PubMed  CAS  Google Scholar 

  12. Buckley R, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE. Development of immunity in human severe primary T-cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 1986; 136:2398.

    Google Scholar 

  13. Dennert G, Anderson CG, Warner J. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: Is there evidence for a dual receptor interaction in acute marrow graft rejection? J Immunol 1986; 136:3981.

    PubMed  CAS  Google Scholar 

  14. Von Melchner H, Bartlett PF. Mechanisms of early allogeneic marrow graft rejection. Immunol Rev 1983; 71:31.

    Article  Google Scholar 

  15. Aizawa S, Sado T, Kamisaku H, Eiko K. Cellular basis of the immunohematologic defects observed in short-term semiallogeneic B6C3F1 → C3H chimeras: Evidence for host-versus-graft reaction initiated by radioresistant T cells. Cell Immunol 1980; 56:47.

    Article  PubMed  CAS  Google Scholar 

  16. Schwartz E, Lapidot T, Gozes D, Singer TS, Reisner Y. Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors, J Immunol 1987; 138:460.

    PubMed  CAS  Google Scholar 

  17. Cobbold SP, Martin G, Qin S, Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323:164.

    Article  PubMed  CAS  Google Scholar 

  18. Reisner Y, Ben-Bassat I, Douer D, Kaploon A, Schwartz E, Ramot B. Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation, Proc Natl Acad Sci USA 1986; 83:4012.

    Article  PubMed  CAS  Google Scholar 

  19. Butturini A, Seeger RC, Gale RP. Recipient immune competent T lymphocytes can survive intensive conditioning for bone marrow transplantation. Blood 1986; 68:954.

    PubMed  CAS  Google Scholar 

  20. Kernan NA, Flomenberg N, Dupont B, O’Reilly RJ. Identification of cytotoxic T lymphocytes in patients rejecting T-cell-depleted bone marrow transplants for leukemia. Blood 1984; 64(1):216a.

    Google Scholar 

  21. Reisner Y. Graft-versus-host disease and graft rejection: Competing factors in bone marrow transplantation. In: Recent Advances in Bone Marrow Transplantation, Gale RP, Champlin R, eds. Alan R Liss, New York, 1987:175.

    Google Scholar 

  22. Reisner Y, Lapidot T, Singer TS, Schwartz E. The host barrier in animal models of T-cell-depleted allogeneic bone marrow transplantation. In: T Cell Depletion in Allogeneic Bone Marrow Transplantation, Martelli MF, Grignani F, Reisner Y, eds. Ares-Serono Symposia, Rome, 1988:37.

    Google Scholar 

  23. Lapidot T, Singer TS, Salomon O, Terenzi A, Schwartz E, Reisner Y. Booster irradiation to the spleen following total body irradiation: A new immunosuppressive approach for allogeneic bone marrow transplantation. J Immunol 1988; 141:2619.

    Google Scholar 

  24. Van Bekkum DW, Löwenberg B, eds. Bone Marrow Transplantation: Biological Mechanisms and Clinical Practice. Marcel Dekker, New York, 1985.

    Google Scholar 

  25. Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hemopoietic stem cell transplantation using mouse bone-marrow and spleen cells fractionated by lectins. Proc Natl Acad Sci USA 1978; 75:2933.

    Google Scholar 

  26. Reisner Y, Ikehara S, Hodes MZ, Good RA. Allogeneic hemopoietic stem cell transplantation using mouse spleen cells fractionated by lectins: In vitro study of cell fractions. Proc Natl Acad Sci USA 1980; 77:1164.

    Article  PubMed  CAS  Google Scholar 

  27. Lapidot T, Singer TS, Reisner Y. Transient engraftment of T-cell-depleted allogeneic bone marrow in mice improves survival rate following lethal irradiation. Bone Marrow Transplant 1988; 3:157.

    PubMed  CAS  Google Scholar 

  28. Aizawa S, Sado T, Kamisaku H, Eiko K. Cellular basis of the immunohematologic defects observed in short-term semiallogeneic B6C3F! → C3H chimeras: Evidence for host-versus-graft reaction initiated by radioresistant T cells. Cell Immunol 1980; 56:47.

    Article  PubMed  CAS  Google Scholar 

  29. Thierfelder S, Kummer U, Schuh R, Mysliwietz J. Antilymphocytic antibodies and marrow transplantation. VIII. Recipient conditioning with Clq-affine monoclonal anti-pan T antibodies prevents GVHD in homozygous fully mismatched mice. Blood 1987; 68:818.

    Google Scholar 

  30. Soderling CB, Song CW, Blazer BR, Vallera DA. A correlation between conditioning and engraftment in recipients of MHC mismatched T-cell-depleted murine bone marrow transplants, Immunology 1985; 135:941.

    CAS  Google Scholar 

  31. Ferrara J, Lipton J, Hellman S, Burakoff S, Mauch P. Engraftment following T-cell-depleted marrow transplantation. I. The role of major and minor histocompatibility barriers. Transplantation 1987; 43:461.

    Article  PubMed  CAS  Google Scholar 

  32. Lapidot T, Terenzi A, Singer TS, Reisner Y. Size of bone marrow inoculum versus number of donor-type cells used for presensitization: A murine model for bone marrow allograft rejection in leukemia patients. Blood 1987; 70(5):309a.

    Google Scholar 

  33. Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y. Stem Cell competition vs. immunological rejection in murine models for bone marrow allograft rejection. J Cell Biochem 1988; Suppl 12C:76.

    Google Scholar 

  34. Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood 1989; 73(7):2025–2032.

    PubMed  CAS  Google Scholar 

  35. Waldmann H, Polliak A, Hale G, Or R, Cividalli G, Weiss L, Weshler Z, Samuel S, Manor D, Brautbar C, Rachmilewitz EA, Slavin S. Elimination of graft versus host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (campath-1). Lancet 1984; 2:483.

    Article  PubMed  CAS  Google Scholar 

  36. Mitsuyasu RT, Champlin RE, Ho WG, Winston D, Feig S, Wells J, Terasaki P, Billings R, Weaver M, Gale RP. Prospective randomized controlled trial of ex-vivo treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for prevention of graft-versus-host disease: A preliminary report. Transplant Proc 1985; 17:482.

    Google Scholar 

  37. Martin PJ, Hansen JA, Buckner CD, Sanders JE, Deeg J, Stewart P, Appelbaum FR, Clift R, Fefer A, Witherspoon RP, Kennedy MS, Sullivan KM, Flournoy N, Storb R, Thomas ED. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 1985; 66:664.

    PubMed  CAS  Google Scholar 

  38. Mugishima H, Terasaki P, Sueyoshi A. Bone marrow from cadaver donors for transplantation. Blood 1985; 65:392.

    PubMed  CAS  Google Scholar 

  39. Blazar BR, Widmer MB, Soderling CCB, Urdal DL, Gillis S, Robison LL, Vallera DA. Augmentation of donor bone marrow engraftment in histocompatible murine recipients by granuloctye/marcophage colony-stimulating factor. Blood 1988; 71:320.

    PubMed  CAS  Google Scholar 

  40. Samlowski WE, Daynes RA. Bone marrow engraftment efficiency is enhanced by competitive inhibition of the hepatic asialoglycoprotein receptor. Proc Natl Acad Sci USA 1985; 82:2508.

    Google Scholar 

  41. Or R, Weshler Z, Lugassy G, Steiner-Salz D, Galun E, Weiss L, Samuel S, Polliac A, Rachmilewitz EA, Waldmann H, Slavin S. Total lymphoid irradiation (TLI) as adjunct immunosuppressor for preventing late graft failure (LGF) associated with T-cell depleted marrow allograft. Exp Hematol 1985; 13:209.

    PubMed  Google Scholar 

  42. Maraninchi D, Blaise D, Rio B, Leblond V, Dreyfus F, Gluckman E, Guyotat D, Pico JL, Michallet M, Ifrah N, Bordigoni A. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias. Lancet 1987; 2:175.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Yair Reisner
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. MD Anderson Cancer Center, Houston, Texas, USA

    Richard Champlin M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Reisner, Y. (1990). Engraftment of T-cell-depleted bone marrow in murine models for allogeneic bone marrow transplantation. In: Champlin, R. (eds) Bone Marrow Transplantation. Cancer Treatment and Research, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1493-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1493-6_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8803-9

  • Online ISBN: 978-1-4613-1493-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation